These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 23020057)

  • 1. Is the advancement of diabetic angiopathy evaluated as ankle-brachial index directly associated with current glycaemic control?
    Dziemidok P; Szcześniak G; Kostrzewa-Zabłocka E; Paprzycki P; Korzon-Burakowska A
    Ann Agric Environ Med; 2012; 19(3):563-6. PubMed ID: 23020057
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Higher arterial stiffness, greater peripheral vascular resistance and lower blood flow in lower-leg arteries are associated with long-term hyperglycaemia in type 2 diabetic patients with normal ankle-brachial index.
    Suzuki E; Yoshimura T; Omura Y; Sakaguchi M; Nishio Y; Maegawa H; Hisatomi A; Fujimoto K; Takeda J; Kashiwagi A
    Diabetes Metab Res Rev; 2009 May; 25(4):363-9. PubMed ID: 19334018
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Automated ankle-brachial pressure index measurement by clinical staff for peripheral arterial disease diagnosis in nondiabetic and diabetic patients.
    Clairotte C; Retout S; Potier L; Roussel R; Escoubet B
    Diabetes Care; 2009 Jul; 32(7):1231-6. PubMed ID: 19366974
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Association between hemoglobin A1c, carotid atherosclerosis, arterial stiffness, and peripheral arterial disease in Korean type 2 diabetic patients.
    Choi SW; Shin MH; Yun WJ; Kim HY; Lee YH; Kweon SS; Rhee JA; Choi JS
    J Diabetes Complications; 2011; 25(1):7-13. PubMed ID: 20106681
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Association of serum podocalyxin levels with peripheral arterial disease in patients with type 2 diabetes.
    El-Ashmawy HM; Selim FO; Hosny TAM; Almassry HN
    J Diabetes Complications; 2019 Jul; 33(7):495-499. PubMed ID: 31097305
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Peripheral arterial disease in black African diabetics: epidemioclinical, ultrasonographic profile and determining factors].
    Mahamat-Azaki O; Zakaria AZ; Oumar A; Mahamat YK; Ali AA; Lackdjoulki D; Soya E
    Ann Cardiol Angeiol (Paris); 2024 Jun; 73(3):101736. PubMed ID: 38636245
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Associations of plasma von Willebrand factor ristocetin cofactor activity and 5-hydroxyindole acetic acid concentrations with blood flow in lower-leg arteries in Japanese type 2 diabetic patients with normal ankle-brachial index.
    Murase H; Suzuki E; Tajima Y; Hayashi K; Nakamura T; Noritake N; Takeda J
    J Diabetes Complications; 2012; 26(2):113-7. PubMed ID: 22459244
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The rise and fall of HbA(1c) as a risk marker for diabetes complications.
    Kilpatrick ES
    Diabetologia; 2012 Aug; 55(8):2089-91. PubMed ID: 22711013
    [TBL] [Abstract][Full Text] [Related]  

  • 9. HbA1c and peripheral arterial disease in diabetes: the Atherosclerosis Risk in Communities study.
    Selvin E; Wattanakit K; Steffes MW; Coresh J; Sharrett AR
    Diabetes Care; 2006 Apr; 29(4):877-82. PubMed ID: 16567831
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Association of HbA1c levels with vascular complications and death in patients with type 2 diabetes: evidence of glycaemic thresholds.
    Zoungas S; Chalmers J; Ninomiya T; Li Q; Cooper ME; Colagiuri S; Fulcher G; de Galan BE; Harrap S; Hamet P; Heller S; MacMahon S; Marre M; Poulter N; Travert F; Patel A; Neal B; Woodward M;
    Diabetologia; 2012 Mar; 55(3):636-43. PubMed ID: 22186981
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Short-term impact of HbA1c on morbidity and all-cause mortality in people with type 2 diabetes: a Danish population-based observational study.
    Skriver MV; Støvring H; Kristensen JK; Charles M; Sandbæk A
    Diabetologia; 2012 Sep; 55(9):2361-70. PubMed ID: 22736395
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Advanced glycation end products and antioxidant status in type 2 diabetic patients with and without peripheral artery disease.
    Lapolla A; Piarulli F; Sartore G; Ceriello A; Ragazzi E; Reitano R; Baccarin L; Laverda B; Fedele D
    Diabetes Care; 2007 Mar; 30(3):670-6. PubMed ID: 17327339
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Markers of inflammation in patients with coronary artery disease are also associated with glycosylated haemoglobin A1c within the normal range.
    Gustavsson CG; Agardh CD
    Eur Heart J; 2004 Dec; 25(23):2120-4. PubMed ID: 15571827
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Ankle-Brachial Index Is Independently Associated With Cardiovascular Outcomes and Foot Ulcers in Asian Patients With Type 2 Diabetes Mellitus.
    Yang MC; Huang YY; Hsieh SH; Sun JH; Wang CC; Lin CH
    Front Endocrinol (Lausanne); 2021; 12():752995. PubMed ID: 34867797
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Glycemic control, lipid-lowering treatment, and prognosis in diabetic patients with peripheral atherosclerotic disease.
    Feringa HH; Karagiannis SE; Vidakovic R; Elhendy A; Schouten O; Boersma E; Bax JJ; Poldermans D
    Ann Vasc Surg; 2007 Nov; 21(6):780-9. PubMed ID: 17980797
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Association of plasma fetuin-a levels with peripheral arterial disease and lower extremity arterial calcification in subjects with type 2 diabetes mellitus.
    Eleftheriadou I; Grigoropoulou P; Kokkinos A; Mourouzis I; Perrea D; Katsilambros N; Sfikakis PP; Tentolouris N
    J Diabetes Complications; 2017 Mar; 31(3):599-604. PubMed ID: 27899247
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Predictors of decrease in ankle-brachial index among patients with diabetes mellitus.
    Hoe J; Koh WP; Jin A; Sum CF; Lim SC; Tavintharan S
    Diabet Med; 2012 Sep; 29(9):e304-7. PubMed ID: 22587456
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Decline in ankle-brachial index is stronger in poorly than in well controlled diabetes: Results from the Heinz Nixdorf Recall cohort study.
    Kowall B; Erbel R; Moebus S; Lehmann N; Kröger K; Stang A
    Atherosclerosis; 2019 May; 284():37-43. PubMed ID: 30870706
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comorbidity and glycemic control in patients with type 2 diabetes.
    El-Kebbi IM; Ziemer DC; Cook CB; Miller CD; Gallina DL; Phillips LS
    Arch Intern Med; 2001 May; 161(10):1295-300. PubMed ID: 11371257
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Significant correlation of glycated albumin, but not glycated haemoglobin, with arterial stiffening in haemodialysis patients with type 2 diabetes.
    Kumeda Y; Inaba M; Shoji S; Ishimura E; Inariba H; Yabe S; Okamura M; Nishizawa Y
    Clin Endocrinol (Oxf); 2008 Oct; 69(4):556-61. PubMed ID: 18248645
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.